Sickle Cell Trait in Football Players

• ClinicalTrials.gov Identifier: NCT01891877
• Recruitment Status: Unknown
• First Posted: July 3, 2013
• Last Update Posted: October 20, 2014
• Sponsor: University of South Florida
• Information provided by (Responsible Party): Carroll Flansburg, University of South Florida

Study Description

Brief Summary:

This study will look at the five different types of sickle cell and their relation to self-reported ill health to determine whether or not one or two of the sickle cell haplotypes are correlated with worse health outcomes. Participants can do complete the study in under half an hour in the privacy of their own home.

Condition or disease
Sickle Cell Trait

Detailed Description:

Sickle cell anemia is a disease which results from the inheritance of two hemoglobin S (Hb S) genes. Sickle-cell anemia individuals are referred to as Hb SS patients, and are known to suffer from a variety of life-threatening symptoms. Paramount in the clinical complications of sickle cell patients is the "sickle-cell crisis". If a crisis is not stopped by prompt medical attention, it may result in death. It is becoming increasingly clear that some sickle cell anemic patients have more benign clinical profiles than do others. The genetic reason for such clinical differences has been well determined: although the mutation that changes the "normal" hemoglobin gene is the same in all patients, the genetic material outside of the gene influences how the gene is expressed. This genetic material is referred to as the beta-globin haplotype. Carriers of the sickle cell gene are referred to as Hb AS individuals. Hb AS carriers usually have a normal life free of the clinical problems associated with the disease suffered by sickle cell patients. However, it is becoming increasingly clear that under strenuous situations, some Hb AS carriers do experience heat illness and other life threatening problems while others do not. The purpose of this project is to determine if there is a genetic reason for why some athlete carriers of the sickle cell trait experience heat illness, while others do not. Although the genetic reason for the different clinical outcomes of sickle cell anemic patients is now well understood (different haplotypes result in different disease courses), the possibility that the same haplotypes might be the reason why some sickle cell carriers have worse clinical profiles has never been explored. In this project we will work with a sickle-cell trait registry of athletes, and we will test the haplotypes of Hb AS athletes who have and who have not had heat illness. Our study is the first to attempt to clarify if there is a genetic reason for this occurrence. Total participation time for the study is thirty minutes or less. Information provided by the participant will be analyzed within one year of participation. Deidentified results will be kept for five years, per the University of South Florida's Institutional Review Board protocol, and will be available upon request to the principal investigator. Participants can do complete the study in under half an hour in the privacy of their own home.

Study Design

• Study Type: Observational
• Estimated Enrollment: 20 participants
• Observational Model: Case-Control
• Time Perspective: Retrospective
• Official Title: Is Sickle Cell Trait as Benign as is Usually Assumed?
• Study Start Date: October 2012
• Estimated Primary Completion Date: December 2015
• Estimated Study Completion Date: December 2015

Groups and Cohorts

Group/Cohort
Current or Former Football Players; Any former or current high school or college football players who carries sickle cell trait.

Outcome Measures

Primary Outcome Measures :

1. Poor health outcomes [ Time Frame: 30 minutes or less to complete survey and buccal swab ]
   Any ill health events, such as excessive dehydration, muscle cramping, fatigue, shortness of breath, sickling crises, that can be linked to a sickling event.

Biospecimen Retention:   Samples With DNA

Buccal swabs will be collected from each participant.

Eligibility Criteria

• Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: Male
• Accepts Healthy Volunteers: Yes
• Sampling Method: Non-Probability Sample

Study Population

The study population consists of adult males who currently or formerly played high school or college football and know that they carry sickle cell trait.

Criteria

Inclusion Criteria:

• over the age of 18
• male
• has previously played or currently plays high school or college football
• carries sickle cell trait

Exclusion Criteria:

• under the age of 18
• female
• does not carry sickle cell trait
• has not played or does not play high school or college football

Contacts and Locations

Contacts

Contact: Carroll N Flansburg, in progress; 8025851054; cflansbu@mail.usf.edu

Contact: Lorena Madrigal, PhD Anthropology; 8139742138; madrigal@usf.edu

Locations

United States, Florida

University of South Florida; Recruiting

Tampa, Florida, United States, 33620

Principal Investigator: Carroll N Flansburg, in progress

Sponsors and Collaborators

University of South Florida

Investigators

• Principal Investigator: Carroll N Flansburg, in progress; University of South Florida

More Information

• Responsible Party: Carroll Flansburg, Research Coordinator, University of South Florida
• ClinicalTrials.gov Identifier: NCT01891877
• Other Study ID Numbers: SCT in Football; NCAA ( Other Identifier: National Collegiate Athletic Association )
• First Posted: July 3, 2013
• Last Update Posted: October 20, 2014
• Last Verified: October 2014

Keywords provided by Carroll Flansburg, University of South Florida:

Sickle Cell Trait; Football; Sickling; Heat Illness; SCT

Additional relevant MeSH terms:

Sickle Cell Trait; Anemia, Sickle Cell; Anemia, Hemolytic, Congenital; Anemia, Hemolytic; Anemia; Hematologic Diseases; Hemoglobinopathies; Genetic Diseases, Inborn